Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2024). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-024-01434-4